Personalized medicine breakthrough for childhood leukemia
Researchers from Newcastle University and Great Ormond Street Hospital have identified new predictors of relapse in children and young people with acute lymphoblastic leukemia (ALL) treated with the immunotherapy drug blinatumomab, as part of a U.K.-wide study.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
How trustworthy is AI breast cancer detection? New method gauges uncertainty for individual patients
United Kingdom
-
AAO: Association between GLP-1 receptor agonists and age-related macular degeneration explored
United Kingdom
-
After stroke and AFib, restoring heart rhythm linked to lower risk of another stroke
United Kingdom
-
Newer anticoagulants may help prevent strokes in AFib patients with previous brain bleeds
United Kingdom
-
Air pollution and temperature variability are associated with higher blood glucose levels
United Kingdom
-
Celebrity Traitors: Neuroscientist on whether you can really make someone yawn by faking it
United Kingdom
-
STI rates drop following antibiotic use recommendations for gay and bisexual men
United Kingdom
-
Study finds health care provider photos in waiting rooms can strengthen patient trust
United Kingdom